Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

• Morgan Stanley 22^nd Annual Global Healthcare Conference
  Date and Time: Wednesday, September 4 at 4:05 p.m. ET

• Baird Global Healthcare Conference
  Date and Time: Wednesday, September 11 at 10:15 a.m. ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]

Media Contact:
Alyssa Horowitz
[email protected]

You May Also Be Interested In

• Hitskope Music Group Unifies Distribution, Rights Management, and Fan Royalties Under One Platform, Founder Danny Barros Says
• Mouser Releases New Qorvo eBook on RF Solutions for Drones, SATCOM and IIoT Next-Generation Markets
• The Voice of Emerita Shareholders Has Been Heard